Multiple Myeloma (MM) Completed Phase 3 Trials for Plerixafor (DB06809)

Also known as: MULTIPLE MYELOMA (MM) / Multiple myeloma / Myeloma, Multiple / Multiple Myelomas / Multiple Myeloma(MM) / Plasma cell myelomas / Myelomatosis multiple / Peripheral plasma cell myeloma / Myelomatosis / Multiple myeloma myelomatosis / Plasma cell myeloma / Myeloma / Multiple myeloma with failed remission

IndicationStatusPhase
DBCOND0040908 (Multiple Myeloma (MM))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00103662Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma PatientsTreatment